Marano C W, Szwergold B S, Kappler F, Brown T R, Matschinsky F M
Diabetes Research Center, University of Pennsylvania, Philadelphia.
Invest Ophthalmol Vis Sci. 1992 Aug;33(9):2619-25.
Confluent human retinal pigmented epithelial cells were cultured on microcarrier beads in the presence of 5.6 or 26 mmol/l glucose with or without the aldose-reductase inhibitor Sorbinil (200 microM) for 2 wk. At the end of the incubation period, perchloric acid extracts were prepared and analyzed by 31P nuclear magnetic resonance spectroscopy. As assessed by this method, the phosphorylated metabolites of cells incubated with 5.6 or 26 mmol/l glucose differed significantly in the concentrations of a number of uridine diphosphate (UDP)-conjugated monosaccharides, which were elevated two- to threefold in cells incubated in 26 mmol/l glucose over control samples. The affected metabolites were identified (through a series of spiking experiments) to be UDP-N-acetylglucosamine, UDP-N-acetylgalactosamine, and UDP-glucuronic acid. Coincubation of the cells with Sorbinil 200 microM in the presence of 26 mmol/l glucose had no effect on this accumulation. Under normal circumstances, these molecules selectively and sequentially are incorporated into the polysaccharide chains of glycosaminoglycans (GAGs), whose presence and distribution in the basement membranes is affected adversely by diabetes mellitus. These data suggest that the availability of the monosaccharide precursor is not the rate-limiting step for GAG synthesis in the presence of pathologic glucose concentrations. Thus, the lost GAG content in the basement membranes of diabetic patients may be caused by changes elsewhere in the biosynthesis and/or catabolism of the polysaccharide-linked protein molecules.
将汇合的人视网膜色素上皮细胞接种于微载体珠上,在含有5.6或26 mmol/L葡萄糖的条件下培养2周,同时添加或不添加醛糖还原酶抑制剂索比尼尔(200 μmol/L)。在孵育期结束时,制备高氯酸提取物并通过31P核磁共振波谱进行分析。通过该方法评估,在5.6或26 mmol/L葡萄糖中孵育的细胞的磷酸化代谢物在一些尿苷二磷酸(UDP)结合的单糖浓度上有显著差异,在26 mmol/L葡萄糖中孵育的细胞中这些单糖浓度比对照样品升高了两到三倍。通过一系列加标实验确定受影响的代谢物为UDP-N-乙酰葡糖胺、UDP-N-乙酰半乳糖胺和UDP-葡糖醛酸。在26 mmol/L葡萄糖存在下,细胞与200 μmol/L索比尼尔共同孵育对这种积累没有影响。在正常情况下,这些分子选择性地并依次掺入糖胺聚糖(GAG)的多糖链中,糖尿病会对其在基底膜中的存在和分布产生不利影响。这些数据表明,在病理性葡萄糖浓度存在的情况下,单糖前体的可用性不是GAG合成的限速步骤。因此,糖尿病患者基底膜中丢失的GAG含量可能是由多糖连接蛋白分子生物合成和/或分解代谢其他部位的变化引起的。